EHS
EHS

MD Stem Cells studies treatment for NAION

Steven Levy, MD, and his MD Stem Cells team have seen statistically significant results using stem cells to fight degenerative eye diseases such as retinitis pigmentosa and non-arteritic ischemic optic neuropathy.
In the NAION study, 10 patients with bilateral visual loss due to sequential non-arteritic ischemic optic neuropathy underwent autologous bone marrow-derived stem cell (BMSC) therapy in the Stem Cell Ophthalmology Treatment Study (SCOTS).
Average patient age was 69.8 years, with an average duration of 9.8 years of visual loss.
Affected eyes were treated with either ocular injections of
EHS
Back to top button